跳至主要内容
临床试验/NCT01888588
NCT01888588已完成不适用

Risk of Uncomplicated Peptic Ulcer in the General Population

AstraZeneca1 个研究点 分布在 1 个国家目标入组 4,000 人开始时间: 2012年9月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
4,000
试验地点
1
主要终点
Relative risk (ratio) of uncomplicated peptic ulcer (UPU) associated with low dose ASA, other antiinflammatory drugs and other common drugs for chronic diseases(paracetamol, SSRI, tricyclic antidepressants, anticoagulants, acid suppressing drugs)

研究概览

简要总结

The analyses are conducted in a previous population-based cohort study using The Health Improvement Network database in the UK (Cai et al 2009).The aims of the post hoc analyses are:

To estimate the relative risk of uncomplicated symptomatic peptic ulcer (UPU) associated with use of low dose aspirin (ASA) and other anti-inflammatory drugs (NSAIDs, steroids) in the general population To estimate the dose-response and duration-response associated with use of these drugs To estimate the relative risk of UPU associated with naive/non-naive use of low dose ASA in the general population To evaluate the effect of proton pump inhibitors (PPI) (alone or in combination with anti-inflammatory drugs) on the occurrence of UPU in the general population To investigate the management of low dose ASA/oral antiplatelets after UPU

详细描述

Risk of uncomplicated peptic ulcer in the general population

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
40 Years 至 84 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 40-84 years in 1997-2005 ( see study population description)

排除标准

  • Patients aged below age 40 and 85 years and above ( see study population description)

研究组 & 干预措施

Cases

Patients with symptomatic peptic ulcer (UPU)

干预措施: Risk of symptomatic peptic ulcer (Drug)

Control group

Control group without symptomatic peptic ulcer (UPU).

干预措施: Risk of symptomatic peptic ulcer (Drug)

结局指标

主要结局

Relative risk (ratio) of uncomplicated peptic ulcer (UPU) associated with low dose ASA, other antiinflammatory drugs and other common drugs for chronic diseases(paracetamol, SSRI, tricyclic antidepressants, anticoagulants, acid suppressing drugs)

时间窗: From Januar 1 1997 till December 31 2005, an expected average of 4 years.

Relative risk (ratio) of UPU associated with current use of the different types of drugs versus non-use.

Management of aspirin after uncomplicated peptic ulcer (UPU).

时间窗: From January 1, 1997 till december 31, 2005, an average of 4 years

次要结局

未报告次要终点

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验